You are here: Industry Insights > GMP

News List

eTheRNA Extends mRNA Production Services contractpharma
November 05, 2020
In response to growing international demand, eTheRNA has extended its mRNA production services to include high throughput research grade mRNA in addition to its GMP capabilities.
Valicare Expands Service Portfolio contractpharma
October 29, 2020
Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs.
CellGenix Expands Facility contractpharma
October 15, 2020
CellGenix GmbH, a global supplier of raw and ancillary materials for cell and gene therapies, has completed the second phase of its facility expansion.
BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1 contractpharma
October 15, 2020
BryoLogyx has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations.
Arranta Bio Establishes Commercial-Ready Manufacturing Facility contractpharma
September 30, 2020
Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.
BioNTech to Acquire GMP Manufacturing Site americanpharmaceuticalreview
September 27, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
JanOne Prepares for GMP Production contractpharma
September 17, 2020
Bottling and labeling of clinical trial batches are expected to begin in early October led by Eurofins CDMO.
Luina Bio Expands contractpharma
September 02, 2020
Luina Bio, one of Australia’s most experienced biopharmaceutical contract development and manufacturing (CDMO) organizations, is expanding to meet the increasing demand in the microbiome and recombinant biopharma markets.
JanOne Readies for Clinical GMP Manufacturing Run contractpharma
August 21, 2020
JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation.
Tetra Bio-Pharma and Dalton Pharma Enter GMP Manufacturing Tie-up contractpharma
August 21, 2020
Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page